What is the relationship between smoking and the development of renal (kidney) or hepatic (liver) cysts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Relationship Between Smoking and Renal Cysts

  • There is evidence to suggest that smoking is associated with an increased risk of renal disease, including chronic kidney disease (CKD) 1, 2, 3.
  • Studies have shown that smoking can lead to a decrease in renal function, as measured by glomerular filtration rate (eGFR) 2, 3.
  • The mechanisms underlying the adverse renal effects of smoking are not fully understood, but may involve the activation of non-neuronal nicotinic acetylcholine receptors (nAChRs) and the generation of reactive oxygen species 3.
  • Nicotine, a major component of cigarette smoke, has been shown to increase the severity of renal injury in animal models and to induce transitory increases in blood pressure accompanied by reductions in glomerular filtration rate and effective renal plasma flow in humans 3.

Relationship Between Smoking and Hepatic Cysts

  • There is no direct evidence in the provided studies to suggest a relationship between smoking and the development of hepatic cysts.
  • However, smoking has been shown to be a risk factor for a range of other health problems, including liver disease 4, 5.

Smoking Cessation and Renal Health

  • Quitting smoking has been shown to reduce the risk of renal disease and to improve renal function 1, 2, 5.
  • A study found that subclinical kidney damage associated with smoking can be reversed if patients stop smoking 5.
  • The use of biomarkers such as Neutrophil gelatinase-associated lipocalin, Kidney injury molecule-1, N-acetyl-beta-D-glucosaminidase, transferrin, and ganglioside-activating protein GM2 can be a preventive measure in the development of chronic kidney disease associated with smoking 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.